Thorlef Spickschen, Director at Clovis Oncology, Inc. (CLVS), bought 18,669 shares at $13.00 ($173K) on 2011-11-21, disclosed to the SEC on 2011-11-21.
Open-market purchase of $173k CLVS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,360 | $0 | 0.0% |
| 2 | $13.00 | 13,309 | $173K | 100.0% |
| Total | $9.27 avg | 18,669 | $173K | 100% |
| Filing → |
| CLVS | SELL | 2018-04-09 | $270K | — | Filing → |
| CLVS | SELL | 2018-03-09 | $277K | — | Filing → |
| CLVS | SELL | 2018-02-23 | $270K | — | Filing → |